TVGN Stock Analysis: Buy, Sell, or Hold?
TVGN - Tevogen Bio Holdings Inc. Common Stock
$9.06
0.59 (6.97%)
▲
5d:
+26.01%
30d:
+22.27%
90d:
+4765.74%
BUY
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When TVGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called TVGN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TVGN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: TVGN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: TVGN is currently trading at $9.06, which is considered slightly high relative to its 30-day fair value range of $6.70 to $9.29.
Technical Outlook: Technically, TVGN is in a strong uptrend. Immediate support is located at $6.17, while resistance sits at $12.00. The stock is showing strong short-term momentum, up 7.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $2.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TVGN is in a strong uptrend. Immediate support is located at $6.17, while resistance sits at $12.00. The stock is showing strong short-term momentum, up 7.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $2.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$6.70 -
$9.29
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.6%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.0%)
- BEARISH: Trading 77.9% above Wall St target ($2.00)
Trading Range Analysis
30-Day Trading Range
$6.70 -
$9.29
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$6.17
Resistance Level
$12.00
Current Trend
Strong Uptrend
Technical data as of
Jun 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.91
Wall Street Target
$2.00
(-77.9%)
Share & Embed Analysis
Last updated: June 03, 2026 6:32 PM ET
Data refreshes hourly during market hours. Next update: 7:32 PM
Data refreshes hourly during market hours. Next update: 7:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TVGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Neal Flomenberg
SELL
501 shares
2026-03-13
Neal Flomenberg
SELL
452 shares
2026-03-11
Neal Flomenberg
SELL
19 shares
2026-03-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 66 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 55 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 53 HOLD |
